• Je něco špatně v tomto záznamu ?

The CTLA4 variants may interact with the IL23R- and NOD2-conferred risk in development of Crohn's disease

O. Hradsky, P. Dusatkova, M. Lenicek, J. Bronsky, J. Nevoral, L. Vitek, M. Lukas, I. Zeniskova, O. Cinek,

. 2010 ; 11 () : 91. [pub] 20100610

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc12025653

BACKGROUND: The CTLA4 (cytotoxic T-lymphocyte antigen 4) gene is associated with several immunopathologic diseases and because of its important immuno-regulatory role it may be considered also a plausible candidate for a genetic association with inflammatory bowel diseases. Previously published studies found no association of CTLA4 with Crohn's disease itself, but some indicated an association with its subphenotypes. The aim of this study was to assess the association in the Czech population, using a set of markers shown to associate with other diseases. METHODS: Six polymorphisms within the CTLA4 region were investigated in 333 patients with Crohn's disease and 482 unrelated healthy controls, all Caucasians of Czech origin. The genotypes of the SNPs were determined using the TaqMan SNP genotyping assays. Haplotypes were reconstructed using an expectation-maximization algorithm, and their association with the condition was assessed using log-linear modeling. Then, potential interactions were tested between the CTLA4 variants and other genetic factors known to confer the disease susceptibility. RESULTS: No crude associations with Crohn's disease were found for the tested CTLA4 variants under the log-additive or dominant models. However, when stratified for the genetic risk conferred by the variants in the NOD2 (the p.Leu1007fsX1008, rs5743293) or the IL23R (p.R381Q, rs11209026), a significant negative association emerged for the minor alleles of CTLA4 CT60 (rs3087243), JO31 (rs11571302), JO27-1 (rs11571297) polymorphisms. This negative association with CTLA4 was apparent only in the strata defined by presence minor alleles at the NOD2 rs5743293 (here the CTLA4 CT60 A coffered an OR = 0.43, 95%CI 0.19 - 0.95 for the presence of CT60 A), or IL23R rs11209026 (here the OR for presence of CT60 A was 0.23, 95%CI 0.07 - 0.71). We observed this effect also for the haplotype consisting of minor alleles of the three tightly linked CTLA4 markers. Furthermore, this haplotype was associated with the younger age at diagnosis (OR 1.52, 95%CI 1.09 - 2.11, p = 0.014). CONCLUSIONS: A protective effect of a CTLA4 haplotype was unmasked after stratification for the risk variants in the NOD2 and IL23R genes, and may point towards the biological relevance of the molecule in the pathogenesis of the disease.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12025653
003      
CZ-PrNML
005      
20121206121610.0
007      
ta
008      
120817e20100610enk f 000 0#eng||
009      
AR
024    7_
$a 10.1186/1471-2350-11-91 $2 doi
035    __
$a (PubMed)20537165
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Hradsky, Ondrej $u Department of Pediatrics, University Hospital Motol and Second Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. ondrej.hradsky@lfmotol.cuni.cz
245    14
$a The CTLA4 variants may interact with the IL23R- and NOD2-conferred risk in development of Crohn's disease / $c O. Hradsky, P. Dusatkova, M. Lenicek, J. Bronsky, J. Nevoral, L. Vitek, M. Lukas, I. Zeniskova, O. Cinek,
520    9_
$a BACKGROUND: The CTLA4 (cytotoxic T-lymphocyte antigen 4) gene is associated with several immunopathologic diseases and because of its important immuno-regulatory role it may be considered also a plausible candidate for a genetic association with inflammatory bowel diseases. Previously published studies found no association of CTLA4 with Crohn's disease itself, but some indicated an association with its subphenotypes. The aim of this study was to assess the association in the Czech population, using a set of markers shown to associate with other diseases. METHODS: Six polymorphisms within the CTLA4 region were investigated in 333 patients with Crohn's disease and 482 unrelated healthy controls, all Caucasians of Czech origin. The genotypes of the SNPs were determined using the TaqMan SNP genotyping assays. Haplotypes were reconstructed using an expectation-maximization algorithm, and their association with the condition was assessed using log-linear modeling. Then, potential interactions were tested between the CTLA4 variants and other genetic factors known to confer the disease susceptibility. RESULTS: No crude associations with Crohn's disease were found for the tested CTLA4 variants under the log-additive or dominant models. However, when stratified for the genetic risk conferred by the variants in the NOD2 (the p.Leu1007fsX1008, rs5743293) or the IL23R (p.R381Q, rs11209026), a significant negative association emerged for the minor alleles of CTLA4 CT60 (rs3087243), JO31 (rs11571302), JO27-1 (rs11571297) polymorphisms. This negative association with CTLA4 was apparent only in the strata defined by presence minor alleles at the NOD2 rs5743293 (here the CTLA4 CT60 A coffered an OR = 0.43, 95%CI 0.19 - 0.95 for the presence of CT60 A), or IL23R rs11209026 (here the OR for presence of CT60 A was 0.23, 95%CI 0.07 - 0.71). We observed this effect also for the haplotype consisting of minor alleles of the three tightly linked CTLA4 markers. Furthermore, this haplotype was associated with the younger age at diagnosis (OR 1.52, 95%CI 1.09 - 2.11, p = 0.014). CONCLUSIONS: A protective effect of a CTLA4 haplotype was unmasked after stratification for the risk variants in the NOD2 and IL23R genes, and may point towards the biological relevance of the molecule in the pathogenesis of the disease.
650    _2
$a alely $7 D000483
650    _2
$a CD antigeny $7 D015703
650    _2
$a antigen CTLA-4 $7 D060908
650    _2
$a Crohnova nemoc $x epidemiologie $x genetika $7 D003424
650    _2
$a běloši $x genetika $7 D044465
650    _2
$a genotyp $7 D005838
650    _2
$a haplotypy $7 D006239
650    _2
$a lidé $7 D006801
650    _2
$a idiopatické střevní záněty $x genetika $7 D015212
650    _2
$a polymorfismus genetický $7 D011110
650    _2
$a jednonukleotidový polymorfismus $7 D020641
650    _2
$a rizikové faktory $7 D012307
650    _2
$a cytotoxické T-lymfocyty $7 D013602
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Dusatkova, Petra
700    1_
$a Lenicek, Martin
700    1_
$a Bronsky, Jiri
700    1_
$a Nevoral, Jiri
700    1_
$a Vitek, Libor
700    1_
$a Lukas, Milan
700    1_
$a Zeniskova, Ivana
700    1_
$a Cinek, Ondrej
773    0_
$w MED00008188 $t BMC medical genetics $x 1471-2350 $g Roč. 11(20100610), s. 91
856    41
$u https://pubmed.ncbi.nlm.nih.gov/20537165 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m
990    __
$a 20120817 $b ABA008
991    __
$a 20121206121643 $b ABA008
999    __
$a ok $b bmc $g 947695 $s 782999
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2010 $b 11 $d 91 $e 20100610 $i 1471-2350 $m Bmc medical genetics $n BMC Med Genet $x MED00008188
LZP    __
$a Pubmed-20120817/10/03

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...